Ernexa Therapeutics Inc. (ERNA) Net income 2016–2025
Ernexa Therapeutics Inc. (ERNA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$14.1MFY2025 · since FY2016: -$2.9M → -$14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.1M | +68.4% |
| FY2024 | -$44.5M | -105.6% |
| FY2023 | -$21.7M | +11.8% |
| FY2022 | -$24.6M | +79.9% |
| FY2021 | -$122.5M | -1580.8% |
| FY2020 | -$7.3M | -256.2% |
| FY2019 | -$2.0M | -690.3% |
| FY2018 | -$259,000 | +76.0% |
| FY2017 | -$1.1M | +63.2% |
| FY2016 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice